|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | (2006.01) |
| A61K 9/28 | (2013.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/10 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/30 | (2018.01) | ||
| A61P 25/36 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3578173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19167974.5 |
| Date of filing the European patent application | 2006-02-28 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 05004377 | 2005-02-28 | EP |
| (72) |
Leyendecker, Petra , DE
Smith, Kevin , GB
Hopp, Michael , DE
|
| (73) |
Euro-Celtique S.A. ,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (54) | DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE |
| DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE |